Pediatric lung transplantation for COVID-19: Unique clinical and psychosocial barriers

Anupam Kumar, Gloria W. Li, Justin M. Segraves, Aladdein Mattar, Maheshwari Ramineni, Gabriel Loor, Puneet S. Garcha

Research output: Contribution to journalArticlepeer-review


Background: SARS-CoV-2 infection in the age group of 0–17 years contributes to approximately 22% of all laboratory-confirmed SARS-CoV-2 infections. Fortunately, this age group has a lower death rate (0.5 per 100 000) that accounts for only 4% of the total deaths due to COVID-19. Despite the low mortality rate in the pediatric population, children of minority groups represented 78% of the deaths highlighting the existing disparities in access to health care. Methods: With the emergence of the more contagious COVID-19 variants and the relatively slow pace of vaccination among the pediatric population, it is possible to see more cases of significant lung injury and potential for transplantation for the younger age group. Results: To our knowledge, our patient is the youngest to have undergone lung transplantation for SARS-CoV-2. Conclusion: The case presented unique challenges, particularly in relation to timing for listing and psychosocial support for parents who were his decision makers.

Original languageEnglish (US)
Article numbere14351
JournalPediatric transplantation
Issue number8
StatePublished - Dec 2022
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2022 Wiley Periodicals LLC.


  • COVID-19
  • lung transplantation
  • pediatric

PubMed: MeSH publication types

  • Case Reports


Dive into the research topics of 'Pediatric lung transplantation for COVID-19: Unique clinical and psychosocial barriers'. Together they form a unique fingerprint.

Cite this